Kestra expects $137M FY2027 revenue while targeting 70%+ gross margins in the next few years (NASDAQ:KMTS)
· seekingalpha.com
Kestra Medical (KMTS) Q4 FY2026 earnings call recap: 66% revenue growth, margin expansion, $137M FY2027 outlook, WCD share gains & financing—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...